Brigelius-Floh, R., & Maiorino, M
Hence, the establishment of therapeutic monitoring protocols for the drug is mandatory, and whole blood is the preferred matrix (Figure 2)
Methods: We retrospectively analyzed data of 68 patients with HCC unsuitable for surgical resection or RFA monotherapy due to tumor size, location, or comorbidities such as cardiopulmonary dysfunction, who were treated with PBT (22 patients) or TACE+RFA (46 patients) from January 2010 to March 2022
Choi WH, Cho J (2016) Evolving clinical cancer radiotherapy: concerns regarding normal tissue protection and quality assurance
Consultation with knowledgeable healthcare providers helps optimize glutathione therapy protocols
ACMSD inhibition increased NAD + levels and improved mitochondrial homeostasis 302